As of December 2024 CRISPR Therapeutics has a market cap of ยฃ2.75 Billion. This makes CRISPR Therapeutics the world's 3309th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 23rd, 2024 the market cap of CRISPR Therapeutics was reported to be: